Healthcare provider profile · identity verified

Alese Marie Hernandez

Nurse Practitioner · TORRANCE, CA · NPI 1164039012

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	302	117
Omeprazole	Omeprazole	277	115
Losartan Potassium	Losartan Potassium	264	109
Amlodipine Besylate	Amlodipine Besylate	257	106
Lisinopril	Lisinopril	225	90
Levothyroxine Sodium	Levothyroxine Sodium	172	70
Gabapentin	Gabapentin	168	72
Metformin Hcl	Metformin Hcl	168	68
Albuterol Sulfate Hfa	Albuterol Sulfate	118	68
Furosemide	Furosemide	110	50
Pioglitazone Hcl	Pioglitazone Hcl	108	44
Metoprolol Succinate	Metoprolol Succinate	106	47
Eliquis	Apixaban	99	26
Rosuvastatin Calcium	Rosuvastatin Calcium	98	49
Hydrochlorothiazide	Hydrochlorothiazide	95	38
Fluticasone Propionate	Fluticasone Propionate	94	50
Alprazolam	Alprazolam	89	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	41
Pantoprazole Sodium	Pantoprazole Sodium	85	39
Simvastatin	Simvastatin	81	32
Famotidine	Famotidine	76	33
Atenolol	Atenolol	64	25
Nifedipine Er	Nifedipine	59	24
Meloxicam	Meloxicam	57	19
Metoprolol Tartrate	Metoprolol Tartrate	56	22
Diclofenac Sodium	Diclofenac Sodium	55	31
Hydralazine Hcl	Hydralazine Hcl	54	25
Lorazepam	Lorazepam	49	23
Alendronate Sodium	Alendronate Sodium	48	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	48	44
Tramadol Hcl	Tramadol Hcl	47	23
Clopidogrel	Clopidogrel Bisulfate	44	16
Ibuprofen	Ibuprofen	44	19
Jardiance	Empagliflozin	41	16
Metformin Hcl Er	Metformin Hcl	41	17
Potassium Chloride	Potassium Chloride	41	18
Benazepril Hcl	Benazepril Hcl	39	19
Prednisone	Prednisone	39	30
Carvedilol	Carvedilol	37	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	13
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Azithromycin	Azithromycin	36	34
Escitalopram Oxalate	Escitalopram Oxalate	36	14
Pravastatin Sodium	Pravastatin Sodium	36	14
Sertraline Hcl	Sertraline Hcl	36	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	32
Trazodone Hcl	Trazodone Hcl	32	16
Glipizide	Glipizide	30	14
Allopurinol	Allopurinol	29	13
Januvia	Sitagliptin Phosphate	29	11
Baclofen	Baclofen	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	12
Clonazepam	Clonazepam	27	suppressed
Estradiol	Estradiol	26	13
Meclizine Hcl	Meclizine Hcl	26	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Risperidone	Risperidone	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	13
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	12
Montelukast Sodium	Montelukast Sodium	24	12
Tamsulosin Hcl	Tamsulosin Hcl	24	14
Trulicity	Dulaglutide	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Naproxen	Naproxen	22	12
Ondansetron Odt	Ondansetron	22	18
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Spironolactone	Spironolactone	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Lactulose	Lactulose	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	15
Cefdinir	Cefdinir	19	19
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	13
Valsartan	Valsartan	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fluconazole	Fluconazole	18	17
Hydrocortisone	Hydrocortisone	18	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ozempic	Semaglutide	17	suppressed
Cephalexin	Cephalexin	16	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Diazepam	Diazepam	16	suppressed
Ketoconazole	Ketoconazole	16	11
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Nystatin	Nystatin	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Clotrimazole	Clotrimazole	14	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Mupirocin	Mupirocin	14	13
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Temazepam	Temazepam	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Prolia	Denosumab	12	suppressed
Torsemide	Torsemide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error